SEC Form 4 · accession 0001638599-16-001125
CorMedix Inc. · CRMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Antony Pfaffle
Officer — Interim Chief Medical Officer · Director
Period of report
Jun 20, 2016
Accepted (ET)
Jun 22, 2016 · 4:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001410098
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par value per share | Jun 20, 2016 | M | 10,000 | $0.68 | A | 10,000 | D | |
| Common Stock, $0.001 par value per shareF1 | Jun 20, 2016 | S | 5,000 | $2.1713 | D | 5,000 | D | |
| Common Stock, $0.001 par value per shareF2 | Jun 20, 2016 | S | 5,000 | $2.1424 | D | 0 | D | |
| Common Stock, $0.001 par value per share | Jun 21, 2016 | M | 19,657 | $0.68 | A | 19,657 | D | |
| Common Stock, $0.001 par value per shareF3 | Jun 21, 2016 | S | 9,657 | $2.1208 | D | 10,000 | D | |
| Common Stock, $0.001 par value per shareF4 | Jun 21, 2016 | S | 7,181 | $2.113 | D | 2,819 | D | |
| Common Stock, $0.001 par value per shareF5 | Jun 21, 2016 | S | 2,000 | $2.1529 | D | 819 | D | |
| Common Stock, $0.001 par value per shareF6 | Jun 21, 2016 | S | 819 | $2.2122 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F11 | $0.68 | Jun 20, 2016 | M | 10,000 | A | — | Dec 5, 2022 | Common Stock, $0.001 par value per share | 10,000 | 119,657 | D |
| Stock Option (right to buy)F11 | $0.68 | Jun 21, 2016 | M | 19,657 | A | — | Dec 5, 2022 | Common Stock, $0.001 par value per share | 19,657 | 100,000 | D |
| Stock Option (right to buy)F7 | $2.27 | holding | — | — | — | — | Apr 1, 2024 | Common Stock, $0.001 par value per share | 100,000 | 100,000 | D |
| Stock Option (right to buy)F8 | $2.02 | holding | — | — | — | — | Jan 9, 2024 | Common Stock, $0.001 par value per share | 100,000 | 100,000 | D |
| Stock Option (right to buy)F9 | $2.02 | holding | — | — | — | — | Jan 9, 2024 | Common Stock, $0.001 par value per share | 30,000 | 30,000 | D |
| Stock Option (right to buy)F10 | $0.90 | holding | — | — | — | — | Mar 22, 2023 | Common Stock, $0.001 par value per share | 210,000 | 210,000 | D |
| Stock Option (right to buy)F12 | $2.10 | holding | — | — | — | — | Jan 14, 2021 | Common Stock, $0.001 par value per share | 30,000 | 30,000 | D |
| Stock Option (right to buy)F13 | $3.125 | holding | — | — | — | — | Mar 30, 2020 | Common Stock, $0.001 par value per share | 20,000 | 20,000 | D |
| Stock Option (right to buy)F14 | $5.00 | holding | — | — | — | — | Feb 24, 2025 | Common Stock, $0.001 par value per share | 75,000 | 75,000 | D |
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.16 to $2.19, inclusive.
- F10These options vest based on performance milestones running through December 31, 2014.
- F11These options vested as follows: (a) fifty percent (50%) on the date of the issuance of the CE mark certification, which occurred on July 5th, 2013, and (b) fifty percent (50%) on December 31, 2013.
- F12These options vested on January 14, 2012.
- F13These options vested as follows: 1/3 on March 30, 2010; an additional 1/3 on March 30, 2011; and the remaining 1/3 on March 30, 2012.
- F14These options were granted on February 24, 2015, and vested immediately.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.13 to $2.19, inclusive.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.11 to $2.13, inclusive.
- F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.10 to $2.13, inclusive.
- F5The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.15 to $2.17, inclusive.
- F6The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.20 to $2.22, inclusive.
- F7The options vested 100% on April 2, 2014.
- F8The options vested 100% on January 10, 2014.
- F9The options vest in full on the first anniversary of the date of grant.